Related references
Note: Only part of the references are listed.Calcium phosphate nanoparticles as intrinsic inorganic antimicrobials: mechanism of action
Victoria M. Wu et al.
BIOMEDICAL MATERIALS (2021)
Antibiotic development - economic, regulatory and societal challenges
Christine Ardal et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Magnetic Graphene-Based Sheets for Bacteria Capture and Destruction Using a High-Frequency Magnetic Field
Andri Hardiansyah et al.
NANOMATERIALS (2020)
Nanomaterials-based photothermal therapy and its potentials in antibacterial treatment
Yuan Chen et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Medical costs of keeping the US economy open during COVID-19
Jiangzhuo Chen et al.
SCIENTIFIC REPORTS (2020)
From socio-technical systems to biosocial technical systems: New themes and new guidance for the field of technology in society
Stephen Fox et al.
TECHNOLOGY IN SOCIETY (2020)
Calcium phosphate nanoparticles as intrinsic inorganic antimicrobials: In search of the key particle property
Vuk Uskokovic et al.
BIOINTERPHASES (2019)
Clinical significance of BPI-ANCA detecting in COPD patients with Pseudomonas aeruginosa colonization
Yongjian Tian et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2019)
Differences in Colistin Administration and Bacterial and Treatment Outcomes in Critically III Patients
Sunmi Jung et al.
SCIENTIFIC REPORTS (2019)
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
Juan P. Horcajada et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Measuring the in-hospital costs of Pseudomonas aeruginosa pneumonia: methodology and results from a German teaching hospital
Klaus Kaier et al.
BMC INFECTIOUS DISEASES (2019)
The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance
Paula Peyrani et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2019)
Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
HyeJin Shi et al.
INFECTION AND DRUG RESISTANCE (2019)
Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey
Liang Chen et al.
BMJ OPEN (2018)
Calcium Phosphate Nanoparticles as Intrinsic Inorganic Antimicrobials: The Antibacterial Effect
Victoria M. Wu et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia
Abdul Karim Suleman Cara et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2018)
Intravenous Colistin Monotherapy versus Combination Therapy against Carbapenem-Resistant Gram-Negative Bacteria Infections: Meta-Analysis of Randomized Controlled Trials
I-Ling Cheng et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands
Carin A. Uyl-de Groot et al.
HEALTH ECONOMICS REVIEW (2018)
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016
Meredith A. Hackel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia
Li-Yang Hsu et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis
S. Stefani et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2017)
The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study
Yael Dishon Benattar et al.
CLINICAL INFECTIOUS DISEASES (2016)
Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
Naomi J. Gadsby et al.
CLINICAL INFECTIOUS DISEASES (2016)
Prevalence of Pseudomonas aeruginosa and antimicrobial-resistant Pseudomonas aeruginosa in patients with pneumonia in mainland China: a systematic review and meta-analysis
Chengyi Ding et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients
Oana Ciofu et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
The Formation of Biofilms by Pseudomonas aeruginosa: A Review of the Natural and Synthetic Compounds Interfering with Control Mechanisms
Tsiry Rasamiravaka et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Antibiotic Resistance of Pseudomonas aeruginosa in Pneumonia at a Single University Hospital Center in Germany over a 10-Year Period
Josef Yayan et al.
PLOS ONE (2015)
Aerosolized Colistin Cost-effectiveness
Pavlos M. Myrianthefs et al.
CHEST (2014)
Chronic Obstructive Pulmonary Disease (COPD): Evaluation From Clinical, Immunological and Bacterial Pathogenesis Perspectives
Daniel J. Hassett et al.
JOURNAL OF MICROBIOLOGY (2014)
The Cost Effectiveness of Dry Powder Antibiotics for the Treatment of Pseudomonas aeruginosa in Patients with Cystic Fibrosis
Paul Tappenden et al.
PHARMACOECONOMICS (2014)
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
Dawn M. Sievert et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
The value of single-pathogen antibacterial agents
Brad Spellberg et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
Qin Lu et al.
ANESTHESIOLOGY (2012)
Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis
S. R. Ott et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Community acquired bacterial pneumonia
Stavros Anevlavis et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Effectiveness and Safety of Colistin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections
M. Montero et al.
INFECTION (2009)
Pseudomonas aeruginosa Biofilms in the Respiratory Tract of Cystic Fibrosis Patients
Thomas Bjarnsholt et al.
PEDIATRIC PULMONOLOGY (2009)
Potential for Cost-Savings in the Care of Hospitalized Low-Risk Community-Acquired Pneumonia Patients in China
Qing-tao Zhou et al.
VALUE IN HEALTH (2009)
Epidemiology and etiology of childhood pneumonia
Igor Rudan et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Considerations for infectious disease research and practice
Margaret A. Hamburg
TECHNOLOGY IN SOCIETY (2008)
Sustainable governance of emerging technologies-Critical constellations in the agent network of nanotechnology
Arnim Wiek et al.
TECHNOLOGY IN SOCIETY (2007)
Nanotechnologies: What we do not know
Vuk Uskokovic
TECHNOLOGY IN SOCIETY (2007)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Microcolony formation:: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung
DD Sriramulu et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
Moving the nanoscience and technology (NST) debate forwards: short-term impacts, long-term uncertainty and the social constitution
Alexander Arnall et al.
TECHNOLOGY IN SOCIETY (2005)
Share Paper
